The Patient Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
Activate Your Account with an access code or Create a New Account
Michael Khodadoust
Lymphoma specialist, Medical oncologist, Cutaneous oncology specialist, Hematologist
Instructor, Medicine - Oncology
Practice Areas
Professional Education
- PhD, University of Michigan, Immunology (2010)
- Fellowship: Stanford University Hematology and Oncology Program (2015) CA
- Residency: Stanford University GME (2012) CA
- Internship: Stanford University GME (2011) CA
- Board Certification: Internal Medicine, American Board of Internal Medicine (2013)
- Medical Education: University of Michigan Health System (2010) MI
Honors & Awards
- Dean's Postdoctoral Fellowship, Stanford University (2014)
- Distinction in Academics and Research, University of Michigan, Ann Arbor (2010)
- Fellow Award, Leukemia and Lymphoma Society (2014-)
- Membership, Alpha Omega Alpha (2009)
- Predoctoral Fellowship Award, National Science Foundation (2002)
- Wiliam Dodd Robinson Award, University of Michigan, Ann Arbor (2010)
- Young Investigator Award, Journal of Clinical Oncology, Conquer Cancer Foundation (2015)
Publications
-
Tumor antigen discovery through translation of the cancer genome.
Khodadoust, M. S., & Alizadeh, A. A. (2014). Tumor antigen discovery through translation of the cancer genome. Immunologic Research, 58(2-3), 292–299. -
Value of Surveillance Studies for Patients With Stage I to II Diffuse Large B-Cell Lymphoma in the Rituximab Era.
Hiniker, S. M., Pollom, E. L., Khodadoust, M. S., Kozak, M. M., Xu, G., Quon, A., … Hoppe, R. T. (2015). Value of Surveillance Studies for Patients With Stage I to II Diffuse Large B-Cell Lymphoma in the Rituximab Era. International Journal of Radiation Oncology, Biology, Physics, 92(1), 99–106. -
Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemia.
Khodadoust, M. S., Luo, B., Medeiros, B. C., Johnson, R. C., Ewalt, M. D., Schalkwyk, A. S., … Gotlib, J. (2016). Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemia. Leukemia, 30(4), 947–950. -
The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrity
Kappes, F., Waldmann, T., Mathew, V., Yu, J., Zhang, L., Khodadoust, M. S., … Markovitz, D. M. (2011). The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrity. GENES & DEVELOPMENT, 25(7), 673–678.
-
DEK expression in melanocytic lesions
Kappes, F., Khodadoust, M. S., Yu, L., Kim, D. S. L., Fullen, D. R., Markovitz, D. M., & Ma, L. (2011). DEK expression in melanocytic lesions. HUMAN PATHOLOGY, 42(7), 932–938.
-
Melanoma Proliferation and Chemoresistance Controlled by the DEK Oncogene
Khodadoust, M. S., Verhaegen, M., Kappes, F., Riveiro-Falkenbach, E., Cigudosa, J. C., Kim, D. S. L., … Soengas, M. S. (2009). Melanoma Proliferation and Chemoresistance Controlled by the DEK Oncogene. CANCER RESEARCH, 69(16), 6405–6413.
-
DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress
Kappes, F., Fahrer, J., Khodadoust, M. S., Tabbert, A., Strasser, C., Mor-Vaknin, N., … Ferrando-May, E. (2008). DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress. MOLECULAR AND CELLULAR BIOLOGY, 28(10), 3245–3257.
-
The DEK nuclear autoantigen is a secreted chemotactic factor
Mor-Vaknin, N., Punturieri, A., Sitwala, K., Faulkner, N., Legendre, M., Khodadoust, M. S., … Markovitz, D. M. (2006). The DEK nuclear autoantigen is a secreted chemotactic factor. MOLECULAR AND CELLULAR BIOLOGY, 26(24), 9484–9496.
-
p300/CBP-associated factor drives DEK into interchromatin granule clusters
Cleary, J., Sitwala, K. V., Khodadoust, M. S., Kwok, R. P. S., Mor-Vaknin, N., Cebrat, M., … Markovitz, D. M. (2005). p300/CBP-associated factor drives DEK into interchromatin granule clusters. JOURNAL OF BIOLOGICAL CHEMISTRY, 280(36), 31760–31767.
-
Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens
Khodadoust, M. S., Olsson, N., Wagar, L. E., Haabeth, O. A. W., Chen, B., Swaminathan, K., … Alizadeh, A. A. (2017). Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens. NATURE, 543(7647), 723-?
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Patient Comments
Patients comments are gathered from our Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
SHC Patient, May 2017
I have been in excellent care throughout my chemo treatments and after - I consider Dr. K had a decent one of your finest doctors dealing with. Lymphoma patients at Stanford Medical - and so very caring and nice -
SHC Patient, Mar 2017
The doctors were fabulous -
SHC Patient, Feb 2017
My Dr. "K" was exceptionally kind and concerned in my treatment of lymphoma of the blood cells (non-Hodgkin's) kept me informed - easy to talk to and well liked by me and my family "team" - He is the BEST!!
SHC Patient, Feb 2017
Dr. Khodadoust was an excellent provider he answered all my questions completely & professionally.
SHC Patient, Oct 2016
The doctor showed genuine concern, made me feel as is if he was in a hurry, I felt very relaxed with him. He listened, gave me time to ask questions, and his answers were complete and very helpful. We left the initial appointment feeling that my decision to come to Stanford will be turning point in 20+ year history if care.
SHC Patient, Oct 2016
Dr. Khodadoust has the best bedside manner. He takes as much time as needed to make on comfortable and explains things so I can understand. I can't thank him enough as well as the team for the care they have provided.
SHC Patient, Sep 2016
I feel blessed to be under Dr. Khodadoust's care! He is beyond wonderful.
SHC Patient, Sep 2016
Dr. Khodadoust explained my condition & treatment options clearly, thoroughly & in language I could understand.
SHC Patient, Sep 2016
Dr. K explained my situation as well as the study in layman's terms. I was able to understand & was treated with courtesy & respect.
SHC Patient, Jun 2016
Dr. Khodadoust has been an outstanding care provider - with sincere concern about my treatment and pain management.
SHC Patient, May 2016
I feel very comfortable and at ease w/Dr. Khodadoust.
SHC Patient, May 2017
I have been in excellent care throughout my chemo treatments and after - I consider Dr. K had a decent one of your finest doctors dealing with. Lymphoma patients at Stanford Medical - and so very caring and nice -
SHC Patient, Mar 2017
The doctors were fabulous -
SHC Patient, Feb 2017
My Dr. "K" was exceptionally kind and concerned in my treatment of lymphoma of the blood cells (non-Hodgkin's) kept me informed - easy to talk to and well liked by me and my family "team" - He is the BEST!!
SHC Patient, Feb 2017
Dr. Khodadoust was an excellent provider he answered all my questions completely & professionally.
SHC Patient, Oct 2016
The doctor showed genuine concern, made me feel as is if he was in a hurry, I felt very relaxed with him. He listened, gave me time to ask questions, and his answers were complete and very helpful. We left the initial appointment feeling that my decision to come to Stanford will be turning point in 20+ year history if care.
SHC Patient, Oct 2016
Dr. Khodadoust has the best bedside manner. He takes as much time as needed to make on comfortable and explains things so I can understand. I can't thank him enough as well as the team for the care they have provided.
SHC Patient, Sep 2016
I feel blessed to be under Dr. Khodadoust's care! He is beyond wonderful.
SHC Patient, Sep 2016
Dr. Khodadoust explained my condition & treatment options clearly, thoroughly & in language I could understand.
SHC Patient, Sep 2016
Dr. K explained my situation as well as the study in layman's terms. I was able to understand & was treated with courtesy & respect.
SHC Patient, Jun 2016
Dr. Khodadoust has been an outstanding care provider - with sincere concern about my treatment and pain management.
SHC Patient, May 2016
I feel very comfortable and at ease w/Dr. Khodadoust.